Market Moves
Former Harvard chemistry chair Charles Lieber leads state-funded Shenzhen BCI lab i-BRAIN
Reuters reported on April 30 that Charles Lieber, the former chair of Harvard's chemistry department convicted in December 2021 under the US China Initiative, has been appointed director of i-BRAIN, a newly established BCI institute at the Shenzhen Medical Academy of Research and Translation. The lab gives Lieber access to dedicated nanofabrication, advanced lithography, and primate research facilities at a scale unavailable to him at Harvard. The appointment lands the same week as Axoft's $55M Asian-led Series A — the capital and talent legs of the same bilateral BCI flow.